Geographic Variation in Hospitalization for Lower Respiratory Tract Infections Across One County

Andrew F Beck1, Todd A Florin1, Suzanne Campanella2

  • 1Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

JAMA Pediatrics
|July 21, 2015
PubMed

Insights

Pediatric bronchiolitis and pneumonia hospitalization rates show significant geographic variation linked to socioeconomic factors. Targeted interventions in impoverished areas could improve care and reduce costs for these common childhood illnesses.

Area of Science:

  • Pediatric hospitalizations
  • Geographic health disparities
  • Public health

Background:

  • Bronchiolitis and pneumonia are leading causes of pediatric hospitalizations.
  • Geographic patterns in hospitalization rates can inform targeted healthcare strategies.

Purpose of the Study:

  • To determine geographic variations in lower respiratory tract infection hospitalization rates within a single county.
  • To assess the association between these hospitalization rates and socioeconomic conditions.

Main Methods:

  • Cross-sectional, population-based study of children hospitalized for lower respiratory tract infections (bronchiolitis and pneumonia) between 2010-2013.
  • Geocoding of patient residences to census tracts and linkage with socioeconomic data from the American Community Survey.
  • Calculation of hospitalization rates by census tract and assessment of associations with socioeconomic measures and geographic clustering.

Main Results:

  • Significant variation in bronchiolitis and pneumonia hospitalization rates across census tracts was observed.
  • Hospitalization rates were significantly associated with socioeconomic measures, with higher rates in impoverished, inner-city neighborhoods.
  • Identified 'hot spots' of high hospitalization rates in specific geographic areas.

Conclusions:

  • Pediatric hospitalization rates for bronchiolitis and pneumonia exhibit considerable geographic disparities.
  • These disparities are strongly related to underlying socioeconomic conditions.
  • Targeted clinical and public health interventions can improve management and potentially reduce costs.
Abstract

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
37
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.8K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
58
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
49